다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, v.43 no.9, 2006년, pp.1089 - 1134
Wormser, Gary P. (Divisions of Infectious Diseases and New York University School of Medicine, New York, New York) , Dattwyler, Raymond J. (Divisions of Allergy, Immunology, and Rheumatology, Department of Medicine, New York Medical College, Valhalla, and New York University School of Medicine, New York, New York) , Shapiro, Eugene D. (Departments of Pediatrics and Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford) , Halperin, John J. (Divisions of New York University School of Medicine, New York, New York) , Steere, Allen C. (Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, and Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts) , Klempner, Mark S. (Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts) , Krause, Peter J. (Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children's Medical Center, Hartford) , Bakken, Johan S. (Section of Infectious Diseases, St. Luke's Hospital, Duluth, Minnesota) , Strle, Franc (Department) , Stanek, Gerold , Bockenstedt, Linda , Fish, Durland , Dumler, J. Stephen , Nadelman, Robert B.
AI-Helper
AbstractEvidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the...
Therapy of infectious diseases Wormser 697 2003 Lyme disease
Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents: April 7 Panel on Clinical Practices for Treatment of HIV Infection 2005
Clin Infect Dis Gross 18 421 1994 10.1093/clinids/18.3.421 Purpose of quality standards for infectious diseases
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 53 365 2004 Lyme disease-United States, 2001-2002
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 52 Suppl 1 2005 Summary of notifiable diseases-United States, 2003
N Engl J Med Hayes 348 2424 2003 10.1056/NEJMra021397 How can we prevent Lyme disease?
Pediatrics Needham 75 997 1985 10.1542/peds.75.6.997 Evaluation of five popular methods for tick removal
Scand J Infect Dis Stjernberg 37 361 2005 10.1080/00365540410021216 Detecting ticks on light versus dark clothing
N Engl J Med Fishbein 333 452 1995 10.1056/NEJM199508173330711 Tick-borne diseases-a growing risk
Ann Intern Med Fradin 128 931 1998 10.7326/0003-4819-128-11-199806010-00013 Mosquitoes and mosquito repellents: a clinician's guide
Using insect repellents safely (EPA-735/F-93-052R) US Environmental Protection Agency, Office of Pesticide Programs 1996
Med Vet Entomol Carroll 19 101 2005 10.1111/j.0269-283X.2005.00559.x Repellency of DEET and SS220 applied to skin involves olfactory sensing by two species of ticks
MMWR Morb Mortal Wkly Rep Centers for Disease Control 38 678 1989 Seizures temporally associated with use of DEET insect repellent: New York and Connecticut
Med Lett Drug Ther 45 41 2003 Insect repellents
CMAJ Koren 169 209 2003 DEET-based insect repellents: safety implications for children and pregnant and lactating women
Arch Dermatol Taplin 126 213 1990 10.1001/archderm.1990.01670260083017 Pyrethrins and pyrethroids in dermatology
Med Lett Drug Ther 31 45 1989 Insect repellents
Med Lett Drug Ther 47 46 2005 Picaridin-a new insect repellent
Pediatr Res Vazquez 53 327 2003 Effectiveness of personal protective measures for Lyme disease [abstract 1866]
Mayo Clin Proc Poland 76 713 2001 10.4065/76.7.713 Prevention of Lyme disease: a review of the literature
Wien Klin Wochenschr Wormser 117 385 2005 10.1007/s00508-005-0362-7 Prevention of Lyme borreliosis
Am J Epidemiol Ley 142 Suppl 9 39 1995 10.1093/aje/142.Supplement_9.S39 Case-control study of risk factors for incident Lyme disease in California
N Engl J Med Steere 339 209 1998 10.1056/NEJM199807233390401 Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
JAMA Krause 275 1657 1996 10.1001/jama.1996.03530450047031 Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness
N Engl J Med Nadelman 337 27 1997 10.1056/NEJM199707033370105 Simultaneous human ehrlichiosis and Lyme borreliosis
Clin Infect Dis Krause 34 1184 2002 10.1086/339813 Disease-specific diagnosis of coinfecting tick-borne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease
Clin Infect Dis Belongia 29 1472 1999 10.1086/313532 Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin
Clin Infect Dis Steere 36 1078 2003 10.1086/368187 Prospective study of coinfection in patients with erythema migrans
Am J Epidemiol Campbell 148 1018 1998 10.1093/oxfordjournals.aje.a009568 Estimation of the incidence of Lyme disease
N Engl J Med Nadelman 345 79 2001 10.1056/NEJM200107123450201 Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite
J Infect Dis Costello 159 136 1989 10.1093/infdis/159.1.136 A prospective study of tick bites in an endemic area for Lyme disease
N Engl J Med Shapiro 327 1769 1992 10.1056/NEJM199212173272501 A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites
Am J Dis Child Agre 147 945 1993 The value of early treatment of deer tick bite for the prevention of Lyme disease
J Gen Intern Med Warshafsky 11 329 1996 10.1007/BF02600042 Efficacy of antibiotic prophylaxis for prevention of Lyme disease: a meta-analysis
N Engl J Med Takafuji 310 497 1984 10.1056/NEJM198402233100805 An efficacy trial of doxycycline chemoprophylaxis against leptospirosis
Antimicrob Agents Chemother Zeidner 48 2697 2004 10.1128/AAC.48.7.2697-2699.2004 Sustained-release formulation of doxycycline hyclate for prophylaxis of tick bite infection in a murine model of Lyme borreliosis
Program and abstracts of the 10th International Conference on Lyme Borreliosis and Other Tick-borne Diseases (Vienna, Austria). Austrian Society for Hygeine, Microbiology, and Preventive Medicine Lee 122 2005 What amoxicillin regimen is predicted to be equivalent to a single 200 mg oral dose of doxycycline for prevention of Lyme borreliosis [abstract P208]?
N Engl J Med Magid 327 534 1992 10.1056/NEJM199208203270806 Prevention of Lyme disease after tick bites-a cost effectiveness analysis
Lyme disease Nowakowski 149 1993 Treatment of early Lyme disease: infection associated with erythema migrans
Int J Med Microbiol Hunfeld 291 Suppl 33 125 2002 10.1016/S1438-4221(02)80024-8 Standardized in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents-possible implications for new therapeutic approaches to Lyme disease
Lancet Dattwyler 336 1404 1990 10.1016/0140-6736(90)93103-V Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis
Am J Med Massarotti 92 396 1992 10.1016/0002-9343(92)90270-L Treatment of early Lyme disease
Ann Intern Med Luft 124 785 1996 10.7326/0003-4819-124-9-199605010-00002 Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double blind, randomized, controlled trial
Arthritis Rheum Steere 37 878 1994 10.1002/art.1780370616 Treatment of Lyme arthritis
Wien Klin Wochenchr Maraspin 114 616 2002 Development of erythema migrans in spite of treatment with antibiotics after a tick bite
Ann Intern Med Schlesinger 103 67 1985 10.7326/0003-4819-103-1-67 Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi
Clin Infect Dis Maraspin 22 788 1996 10.1093/clinids/22.5.788 Treatment of erythema migrans in pregnancy
Paediatr Perinat Epidemiol Williams 9 320 1995 10.1111/j.1365-3016.1995.tb00148.x Maternal Lyme disease and congenital malformation: a cord blood serosurvey in endemic and control areas
Am J Obstet Gynecol Strobino 169 367 1993 10.1016/0002-9378(93)90088-Z Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients
Infectious diseases of the fetus and newborn infant Shapiro 6th ed. 485 2006 10.1016/B0-72-160537-0/50017-7 Lyme disease
Pediatr Neurol Gerber 11 41 1994 10.1016/0887-8994(94)90088-4 Childhood neurologic disorders and Lyme disease during pregnancy
Annu Rev Entomol Spielman 30 439 1985 10.1146/annurev.en.30.010185.002255 Ecology of Ixodes dammini-borne human babesiosis and Lyme disease
J Clin Microbiol Pusterla 37 4042 1999 10.1128/JCM.37.12.4042-4044.1999 Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks
Appl Environ Microbiol Wang 69 4561 2003 10.1128/AEM.69.8.4561-4565.2003 Real-time PCR for simultaneous detection and quantification of Borrelia burgdorferi in field-collected Ixodes scapularis ticks from the northeastern United States
Proc Nat Acad Sci U S A Tsao 101 18159 2004 10.1073/pnas.0405763102 An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle
Appl Environ Microbiol Daniels 64 4663 1998 10.1128/AEM.64.12.4663-4669.1998 Geographic risk for Lyme disease and human granulocytic ehrlichiosis in Southern New York State
J Med Entomol Eisen 41 768 2004 10.1603/0022-2585-41.4.768 Life stage-related differences in density of questing ticks and infection with Borrelia burgdorferi sensu lato within a single cohort of Ixodes pacificus (Acari:Ixodidae)
J Parasitol Lane 84 29 1998 10.2307/3284524 Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis)
J Parasitol Ullmann 89 1256 2003 10.1645/Ge-3081RN Bacteriolytic activity of selected vertebrate sera for Borrelia burgdorferi sensu stricto and Borrelia bissettii
J Vector Ecol Piesman 24 91 1999 Geographic survey of vector ticks (I. scapularis and I. pacificus) for infection with the Lyme disease spirochete, Borrelia burgdorferi
J Clin Microbiol Clark 42 5076 2004 10.1128/JCM.42.11.5076-5086.2004 Borrelia species in host-seeking ticks and small mammals in Florida
J Clin Microbiol Oliver 38 120 2000 10.1128/JCM.38.1.120-124.2000 Isolation, cultivation, and characterization of Borrelia burgdorferi from rodents and ticks in the Charleston area of South Carolina
Lyme borreliosis: biology, epidemiology, and control Piesman 223 2002 10.1079/9780851996325.0223 Ecology of Borrelia burgdorferi sensu lato in North America
Clin Infect Dis Dennis 41 966 2005 10.1086/432958 Rash decisions: Lyme disease, or not?
Clin Infect Dis Wormser 41 958 2005 10.1086/432935 Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions
J Infect Dis James 183 1810 2001 10.1086/320721 Borrelia lonestari infection after a bite by an Amblyomma americanum tick
Clin Infect Dis Wormser 40 423 2005 10.1086/427289 Microbiologic evaluation of patients from Missouri with erythema migrans
J Infect Dis Sood 175 996 1997 10.1086/514009 Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic
Am J Epidemiol Falco 143 187 1996 10.1093/oxfordjournals.aje.a008728 Duration of tick bites in a Lyme disease-endemic area
BMJ Cook 310 452 1995 10.1136/bmj.310.6977.452 Number needed to treat: a clinically useful measure of treatment effect
N Engl J Med Schwartz 337 49 1997 10.1056/NEJM199707033370111 Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease
Am J Epidemiol Falco 149 771 1999 10.1093/oxfordjournals.aje.a009886 Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans
J Clin Microbiol Piesman 25 557 1987 10.1128/JCM.25.3.557-558.1987 Duration of tick attachment and Borrelia burgdorferi transmission
J Infect Dis Piesman 163 895 1991 10.1093/infdis/163.4.895 Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi with description of a needle aspiration isolation method
J Parasitol Peavey 81 175 1995 10.2307/3283916 Transmission of Borrelia burgdorferi by Ixodes pacificus nymphs and reservoir competence of deer mice (Peromyscus maniculatus) infected by tick-bite
Proc Natl Acad Sci U S A Ohnishi 98 670 2001 10.1073/pnas.98.2.670 Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks
J Med Entomol Ribeiro 24 201 1987 10.1093/jmedent/24.2.201 Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae)
Zentralbl Bakteriol Kahl 287 41 1998 10.1016/S0934-8840(98)80142-4 Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal
Vector Borne Zoonotic Dis Crippa 2 3 2002 10.1089/153036602760260724 Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks
Am J Trop Med Hyg Piesman 29 742 1980 10.4269/ajtmh.1980.29.742 Human babesiosis on Nantucket Island: prevalence of Babesia microti in ticks
Infect Immun Das 66 1803 1998 10.1128/IAI.66.4.1803-1805.1998 Granulocytic ehrlichiosis in tick-immune guinea pigs
Proc Natl Acad Sci U S A Telford 93 6209 1996 10.1073/pnas.93.12.6209 Perpetuation of the agent of human granulocytic ehrlichiosis deer tick-rodent cycle
J Infect Dis des Vignes 183 773 2001 10.1086/318818 Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs
N Engl J Med Saltzman 328 137 1993 Prevention of Lyme disease after tick bites [letter]
Program and abstracts of the 9th International Conference on Lyme Borreliosis and Other Tick-borne Diseases (New York) Nowakowski 2003 Evaluation of an interactive training program on Lyme disease for health care providers [abstract P-78]
Programs and abstracts of the 10th International Conference on Lyme Borreliosis and Other Tick-borne Diseases (Vienna, Austria). Austrian Society for Hygeine, Microbiology, and Preventive Medicine Falco 120 2005 Evaluation of patient assessment of tick bite duration and eligibility for Lyme disease prophylaxis in a clinical setting [abstract P203]
N Engl J Med Gerber 335 1270 1996 10.1056/NEJM199610243351703 Lyme disease in children in southeastern Connecticut
N Engl J Med Wormser 336 1107 1997 10.1056/NEJM199704103361517 Lyme disease in children [letter]
N Engl J Med Sigal 339 216 1998 10.1056/NEJM199807233390402 A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease
Rev Infect Dis Berger 11 Suppl 6 1475 1989 10.1093/clinids/11.Supplement_6.S1475 Dermatologic manifestations of Lyme disease
Am J Med Nadelman 100 502 1996 10.1016/S0002-9343(95)99915-9 The clinical spectrum of early Lyme borreliosis in patients with culture positive erythema migrans
Arch Dermatol Melski 129 709 1993 10.1001/archderm.1993.01680270047005 Primary and secondary erythema migrans in central Wisconsin
Ann Intern Med Steere 99 76 1983 10.7326/0003-4819-99-1-76 The early clinical manifestations of Lyme disease
JAMA Bakken 275 199 1996 10.1001/jama.1996.03530270039029 Clinical and laboratory characteristics of human granulocytic ehrlichiosis
Ann Intern Med Aguero-Rosenfeld 125 904 1996 10.7326/0003-4819-125-11-199612010-00006 Human granulocytic ehrlichiosis: a case series from a single medical center in New York State
Arch Intern Med White 158 2149 1998 10.1001/archinte.158.19.2149 Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors
Clin Infect Dis Steere 37 528 2003 10.1086/376914 Asymptomatic infection with Borrelia burgdorferi
JAMA Brown 282 62 1999 10.1001/jama.282.1.62 Role of serology in the diagnosis of Lyme disease
JAMA Wormser 282 79 1999 10.1001/jama.282.1.79 Lyme disease serology: problems and opportunities
J Clin Microbiol Aguero-Rosenfeld 37 3718 1999 10.1128/JCM.37.11.3718-3721.1999 Effects of Osp A vaccination on Lyme disease serologic testing
Ann Intern Med American College of Physicians 127 1106 1997 10.7326/0003-4819-127-12-199712150-00010 Guidelines for laboratory evaluation in the diagnosis of Lyme disease
Ann Intern Med Tugwell 127 1109 1997 10.7326/0003-4819-127-12-199712150-00011 Clinical guideline, part 2: laboratory evaluation in the diagnosis of Lyme disease
Clin Microbiol Rev Aguero-Rosenfeld 18 484 2005 10.1128/CMR.18.3.484-509.2005 Diagnosis of Lyme borreliosis
Pediatr Infect Dis J Seltzer 15 762 1996 10.1097/00006454-199609000-00003 Misdiagnosis of Lyme disease: when not to order serologic tests
Vaccine Poland 19 2303 2001 10.1016/S0264-410X(00)00520-X The prevention of Lyme disease with vaccine
Am J Med Nadelman 98 Suppl 4A 15 1995 10.1016/S0002-9343(99)80040-0 Erythema migrans and early Lyme disease
N Engl J Med Steere 321 586 1989 10.1056/NEJM198908313210906 Lyme disease
Lancet Nadelman 352 557 1998 10.1016/S0140-6736(98)01146-5 Lyme borreliosis
Lancet Stanek 362 1639 2003 10.1016/S0140-6736(03)14798-8 Lyme borreliosis
Ann Intern Med Smith 136 421 2002 10.7326/0003-4819-136-6-200203190-00005 Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans
N Engl J Med Steere 345 115 2001 10.1056/NEJM200107123450207 Lyme disease
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 46 RR-10 1 1997 Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96)
Ann Intern Med Wormser 142 751 2005 10.7326/0003-4819-142-9-200505030-00011 Brief communication: hematogenous dissemination in early Lyme disease
N Engl J Med Wormser 354 2794 2006 10.1056/NEJMcp061181 Clinical practice: early Lyme disease
Arch Dermatol Goldberg 128 1495 1992 10.1001/archderm.1992.01680210073010 Vesicular erythema migrans
Clin Infect Dis Nowakowski 33 2023 2001 10.1086/324490 Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 44 590 1995 Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 54 125 2005 Notice to readers: caution regarding testing for Lyme disease
J Clin Microbiol Engstrom 33 419 1995 10.1128/JCM.33.2.419-427.1995 Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
J Infect Dis Dressler 167 392 1993 10.1093/infdis/167.2.392 Western blotting in the serodiagnosis of Lyme disease
J Infect Dis Johnson 174 346 1996 10.1093/infdis/174.2.346 Serodiagnosis of Lyme disease: accuracy of a two-step approach using flagella-based ELISA and immunoblotting
Am J Med Hilton 106 404 1999 10.1016/S0002-9343(99)00046-7 Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States
J Clin Microbiol Coulter 43 5080 2005 10.1128/JCM.43.10.5080-5084.2005 Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease
Mol Diagn Dumler 6 1 2001 10.2165/00066982-200106010-00001 Molecular diagnosis of Lyme disease: review and meta-analysis
Antimicrob Agents Chemother Agger 36 1788 1992 10.1128/AAC.36.8.1788 In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone
Eur J Clin Microbiol Mursic 6 424 1987 10.1007/BF02013102 In vitro and in vivo susceptibility of Borrelia burgdorferi
Yale J Biol Med Johnson 57 549 1984 Susceptibility of the Lyme disease spirochete to seven antimicrobial agents
Antimicrob Agents Chemother Johnson 31 164 1987 10.1128/AAC.31.2.164 In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents
Infection Baradaran-Dilmaghani 24 60 1996 10.1007/BF01780660 In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapies
J Clin Microbiol Dever 30 2692 1992 10.1128/JCM.30.10.2692-2697.1992 In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-killing studies
Antimicrob Agents Chemother Levin 37 1444 1993 10.1128/AAC.37.7.1444 In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents
Antimicrob Agents Chemother Johnson 34 2133 1990 10.1128/AAC.34.11.2133 Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents
Arch Fam Med Nowakowski 9 563 2000 10.1001/archfami.9.6.563 Failure of treatment with cephalexin for Lyme disease
Antimicrob Agents Chemother Dever 37 1704 1993 10.1128/AAC.37.8.1704 Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi
Antimicrob Agents Chemother Terekhovo 46 3637 2002 10.1128/AAC.46.11.3637-3640.2002 Erythromycin resistance in Borrelia burgdorferi
Antimicrob Agents Chemother Hunfeld 48 344 2004 10.1128/AAC.48.1.344-347.2004 Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi
Ann Intern Med Steere 99 22 1983 10.7326/0003-4819-99-1-22 Treatment of early manifestations of Lyme disease
Ann Intern Med Nadelman 117 273 1992 10.7326/0003-4819-117-4-273 Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease
Antimicrob Agents Chemother Luger 39 661 1995 10.1128/AAC.39.3.661 Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans
N Engl J Med Dattwyler 337 289 1997 10.1056/NEJM199707313370501 Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease
Pediatrics Eppes 109 1173 2002 10.1542/peds.109.6.1173 Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease
Ann Intern Med Wormser 138 697 2003 10.7326/0003-4819-138-9-200305060-00005 Duration of antibiotic therapy for early Lyme disease: a randomized, double-blind, placebo-controlled trial
Ann Intern Med Steere 93 1 1980 10.7326/0003-4819-93-1-1 Antibiotic therapy in Lyme disease
J Am Acad Dermatol Nowakowski 32 223 1995 10.1016/0190-9622(95)90130-2 Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans
JAMA Luft 267 1364 1992 10.1001/jama.1992.03480100070033 Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection
Med Lett Drug Ther 47 41 2005 Treatment of Lyme disease
Acta Derm Venereol Hansen 72 297 1992 10.2340/0001555572297300 Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans
Antimicrob Agents Chemother Dattwyler 40 468 1996 10.1128/AAC.40.2.468 Clarithromycin in treatment of early Lyme disease: a pilot study
Neurology Halperin 46 619 1996 10.1212/WNL.46.3.619 Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)
Ann N Y Acad Sci Halperin 539 24 1988 10.1111/j.1749-6632.1988.tb31835.x Nervous system abnormalities in Lyme disease
Arch Neurol Finkel 49 102 1992 10.1001/archneur.1992.00530250106024 Nervous system Lyme borreliosis-revisited
Neurology Halperin 39 753 1989 10.1212/WNL.39.6.753 Lyme neuroborreliosis: central nervous system manifestations
Ann Intern Med Steere 107 725 1987 10.7326/0003-4819-107-5-725 The clinical evolution of Lyme arthritis
Medicine Reik 58 281 1979 10.1097/00005792-197907000-00001 Neurologic abnormalities of Lyme disease
Laryngoscope Clark 95 1341 1985 10.1288/00005537-198511000-00009 Facial paralysis in Lyme disease
Arch Pediatr Adolesc Med Shapiro 151 1183 1997 10.1001/archpedi.1997.02170490009001 Lyme disease and facial nerve palsy
Neurology Halperin 42 1268 1992 10.1212/WNL.42.7.1268 Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group
Pediatrics Eppes 103 957 1999 10.1542/peds.103.5.957 Characterization of Lyme meningitis and comparison with viral meningitis in children
Pediatr Infect Dis J Shah 24 542 2005 10.1097/01.inf.0000164767.73746.6e Early differentiation of Lyme from enteroviral meningitis
Pediatrics Rothermel 108 477 2001 10.1542/peds.108.2.477 Optic neuropathy in children with Lyme disease
Clin Infect Dis Nord 37 e25 2003 10.1086/375691 Lyme disease complicated with pseudotumor cerebri
J Infect Dis Bacon 187 1187 2003 10.1086/374395 Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates
Ann N Y Acad Sci Stiernstedt 539 46 1988 10.1111/j.1749-6632.1988.tb31837.x Clinical manifestations and diagnosis of neuroborreliosis
Otol Neurotol Peltomaa 25 838 2004 10.1097/00129492-200409000-00031 The VlsE (IR6) peptide ELISA in the serodiagnosis of Lyme facial paralysis
Ann Neurol Henriksson 20 337 1986 10.1002/ana.410200311 Immunoglobin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Banwarth's syndrome)
J Infect Dis Steere 161 1203 1990 10.1093/infdis/161.6.1203 Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis
J Infect Dis Nocton 174 623 1996 10.1093/infdis/174.3.623 Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis
A Report of the Quality Standards Subcommittee of the American Academy of Neurology Halperin Practice parameter: treatment of nervous system Lyme disease
Ann Intern Med Steere 99 767 1983 10.7326/0003-4819-99-6-767 Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin
Semin Neurol Wormser 17 45 1997 10.1055/s-2008-1040912 Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination
Arch Neurol Pfister 46 1190 1989 10.1001/archneur.1989.00520470044025 Cefotaxime vs. penicillin G for acute neurologic manifestations in Lyme borreliosis: a prospective randomized study
Infection Mullegger 19 279 1991 10.1007/BF01644967 Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children-a prospective study
J Infect Dis Pfister 163 311 1991 10.1093/infdis/163.2.311 Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis
Scand J Infect Dis Suppl Dotevall 53 74 1988 The use of doxycycline in nervous system Borrelia burgdorferi infection
Clin Infect Dis Dotevall 28 569 1999 10.1086/515145 Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis
Neurology Karlsson 44 1203 1994 10.1212/WNL.44.7.1203 Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis
J Neurol Kohlhepp 236 464 1989 10.1007/BF00328508 Treatment of Lyme borreliosis: randomized comparison of doxycycline and penicillin G
Pediatr Infect Dis J Thorstrand 21 1142 2002 10.1097/00006454-200212000-00011 Successful treatment of neuroborreliosis with ten day regimens
Scand J Infect Dis Borg 37 449 2005 10.1080/00365540510027228 Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis
Scand J Infect Dis Karkkonen 33 259 2001 10.1080/003655401300077225 Follow-up of patients treated with oral doxycycline for Lyme borreliosis
J Infect Dis Kalish 183 453 2001 10.1086/318082 Evaluation of study patients with Lyme disease, 10-20 year follow-up
Ann Intern Med Steere 93 8 1980 10.7326/0003-4819-93-1-8 Lyme carditis: cardiac abnormalities of Lyme disease
Am J Med Sigal 98 25 1995 10.1016/S0002-9343(99)80041-2 Early disseminated Lyme disease: cardiac manifestations
Scand J Infect Dis Suppl Van der Linde 77 81 1991 Lyme carditis: clinical characteristics of 105 cases
Am Heart J Cox 122 1449 1991 10.1016/0002-8703(91)90589-A Cardiovascular manifestations of Lyme disease
Ann Intern Med McAlister 110 339 1989 10.7326/0003-4819-110-5-339 Lyme carditis: an important course of reversible heart block
Med Clin North Am Pinto 86 285 2002 10.1016/S0025-7125(03)00087-7 Cardiac manifestations of Lyme disease
Front Biosci Haddad 8 s769 2003 10.2741/1065 Lyme disease and the heart
Ann Intern Med Sangha 128 346 1998 10.7326/0003-4819-128-5-199803010-00002 Lack of cardiac manifestations among patients with previously treated Lyme disease
Am J Cardiol Sonnesyn 76 97 1995 10.1016/S0002-9149(99)80814-5 A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure
Pace Rubin 15 252 1992 10.1111/j.1540-8159.1992.tb06492.x Prospective evaluation of heart block complicating early Lyme disease
Aspects of Lyme borreliosis van der Linde 131 1993 10.1007/978-3-642-77614-4_10 Lyme carditis
Infection Strle 20 201 1992 10.1007/BF02033059 Solitary borrelial lymphocytoma: report of 36 cases
Wien Klin Wochenschr Maraspin 114 515 2002 Solitary borrelial lymphocytoma in adult patients
Eur J Dermatol Muellegger 14 296 2004 Dermatological manifestations of Lyme borreliosis
J Cutan Pathol Colli 31 232 2004 10.1111/j.0303-6987.2003.00167.x Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases
Ann N Y Acad Sci Asbrink 539 4 1988 10.1111/j.1749-6632.1988.tb31833.x Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis)
Zentralbl Bakteriol Hyg [A] Weber 263 209 1986 Clinical features of early erythema migrans and related disorders
Zentralbl Bakteriol Asbrink 156 1989 Lymphadenosis benigna cutis solitaria-borrelia lymphocytoma in Sweden
Infection Strle 24 80 1996 10.1007/BF01780665 Treatment of borrelial lymphocytoma
J Am Acad Dermatol Moreno 48 376 2003 10.1067/mjd.2003.90 Interstitial granulomatous dermatitis with histiocytic pseudorosettes: a new histopathologic pattern in cutaneous borreliosis. Detection of Borrelia burgdorferi DNA sequences by a highly sensitive PCR-ELISA
J Neuroophthalmol Sibony 25 71 2005 10.1097/01.WNO.0000166060.35366.70 Reactive Lyme serology in optic neuritis
Pediatr Res Vazquez 53 327 2003 Accuracy of reporting of Lyme disease in Connecticut [abstract 1867]
Ann Intern Med Steere 86 685 1977 10.7326/0003-4819-86-6-685 Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum
Nat Rev Immunol Steere 4 143 2004 10.1038/nri1267 Elucidation of Lyme arthritis
Med Clin North Am Steere 81 179 1997 10.1016/S0025-7125(05)70510-1 Diagnosis and treatment of Lyme arthritis
N Engl J Med Nocton 330 229 1994 10.1056/NEJM199401273300401 Detection of Borrelia burgdorferi by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
N Engl J Med Logigian 323 1438 1990 10.1056/NEJM199011223232102 Chronic neurologic manifestations of Lyme disease
Semin Neurol Kaplan 17 31 1997 10.1055/s-2008-1040910 Lyme encephalopathy: a neuropsychological perspective
Neurology Kaplan 42 1263 1992 10.1212/WNL.42.7.1263 Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and non-psychotically depressed patients
Neurology Halperin 40 1340 1990 10.1212/WNL.40.9.1340 Lyme borreliosis-associated encephalopathy
Applied Neuropsychol Kaplan 6 3 1999 10.1207/s15324826an0601_1 Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology
Ann N Y Acad Sci Ackermann 539 16 1988 10.1111/j.1749-6632.1988.tb31834.x Chronic neurologic manifestations of erythema migrans borreliosis
Neurology Hammers-Berggren 43 169 1993 10.1212/WNL.43.1_Part_1.169 Borrelia burgdorferi specific intrathecal antibody production in neuroborreliosis: a follow-up study
Neuroradiology Kalina 47 903 2005 10.1007/s00234-005-1440-2 Lyme disease of the brainstem
Neurology Coyle 39 760 1989 10.1212/WNL.39.6.760 Borrelia burgdorferi antibodies in multiple sclerosis patients
Neurology Halperin 41 1571 1991 10.1212/WNL.41.10.1571 Central nervous system abnormalities in Lyme neuroborreliosis
Ann Neurol Coyle 34 745 1993 10.1002/ana.410340521 Significance of reactive Lyme serology in multiple sclerosis
Brain Halperin 113 1207 1990 10.1093/brain/113.4.1207 Lyme neuroborreliosis: peripheral nervous system manifestations
Neurology Halperin 37 1700 1987 10.1212/WNL.37.11.1700 Lyme disease: cause of a treatable peripheral neuropathy
Neurology Vallat 37 749 1987 10.1212/WNL.37.5.749 Tick bite meningoradiculoneuritis
J Infect Dis Logigian 180 377 1999 10.1086/314860 Successful treatment of Lyme encephalopathy with intravenous ceftriaxone
JAMA Steere 288 1002 2002 10.1001/jama.288.8.1002 A 58-year-old man with a diagnosis of chronic Lyme disease
N Engl J Med Steere 312 869 1985 10.1056/NEJM198504043121401 Successful parenteral penicillin therapy of established Lyme arthritis
J Infect Dis Dattwyler 155 1322 1987 10.1093/infdis/155.6.1322 Ceftriaxone as effective therapy for refractory Lyme disease
Lancet Dattwyler 1 1191 1988 10.1016/S0140-6736(88)92011-9 Treatment of late Lyme borreliosis-randomized comparison of ceftriaxone and penicillin
Wien Klin Wochenschr Dattwyler 117 393 2005 10.1007/s00508-005-0361-8 A comparison of two treatment regimens of ceftriaxone in late Lyme disease
J Pediatr Eichenfield 109 753 1986 10.1016/S0022-3476(86)80688-6 Childhood Lyme arthritis: experience in an endemic area
Arch Neurol Fishman 15 113 1966 10.1001/archneur.1966.00470140003001 Blood-brain and CSF barriers to penicillin and related organic acids
N Engl J Med Eckman 337 357 1997 10.1056/NEJM199707313370525 Cost effectiveness of oral as compared with intravenous antibiotic treatment for patients with early Lyme disease or Lyme arthritis
Arthritis Rheum Carlson 42 2705 1999 10.1002/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis
Science Gross 281 703 1998 10.1126/science.281.5377.703 Identification of LFA-1 as a candidate autoantigen in treatment resistant Lyme arthritis
J Exp Med Steere 203 961 2006 10.1084/jem.20052471 Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide
Arthritis Rheum Jaulhac 39 736 1996 10.1002/art.1780390505 Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis
Arthritis Rheum Schoen 34 1056 1991 10.1002/art.1780340817 Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy
Inflammation Malawista 24 493 2000 10.1023/A:1007079705485 Resolution of Lyme arthritis, acute or prolonged: a new look
Clin Orthop Relat Res Battafarano 297 238 1993 10.1097/00003086-199312000-00038 Chronic septic arthritis caused by Borrelia burgdorferi
Arthritis Rheum Steere 54 3079 2006 10.1002/art.22131 Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis
Pediatric Infect Dis J Bloom 17 189 1998 10.1097/00006454-199803000-00004 Neurocognitive abnormalities in children after classic manifestations of Lyme disease
Infection Hassler 18 16 1990 10.1007/BF01644175 Cefotaxime versus penicillin in the late stage of Lyme disease-prospective, randomized therapeutic approach
J Infect Dis Ettestad 171 356 1995 10.1093/infdis/171.2.356 Biliary complications in the treatment of unsubstantiated Lyme disease
Zentralbl Bakteriol Mikrobiol Hyg A Asbrink 263 253 1986 Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients
J Infect Dis Ohlenbush 174 421 1996 10.1093/infdis/174.2.421 Etiology of acrodermatitis chronica atrophicans lesion in Lyme disease
Wien Klin Wochenschr Ruzic-Sabljic 114 544 2002 Characterisation of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia
Zentralbl Bakteriol Mikrobiol Hyg [A] Lavoie 263 262 1986 Acrodermatitis chronica atrophicans with antecedent Lyme disease in a Californian
Cutis DiCaudo 54 81 1994 Acrodermatitis chronica atrophicans in the United States: clinical and histopathologic features of six cases
Wien Klin Wochenschr Maraspin 114 533 2002 Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans
Ann N Y Acad Sci Kristoferitsch 539 35 1988 10.1111/j.1749-6632.1988.tb31836.x Neuropathy associated with acrodermatitis chronica atrophicans: clinical and morphological features
Acta Neurol Scand Kindstrand 95 338 1997 10.1111/j.1600-0404.1997.tb00222.x Peripheral neuropathy in acrodermatitis chronica atrophicans-a late Borrelia manifestation
Wien Klin Wochenschr Strle 111 911 1999 Principles of the diagnosis and antibiotic treatment of Lyme borreliosis
Aspects of Lyme borreliosis Weber 312 1993 10.1007/978-3-642-77614-4_23 Therapy of cutaneous manifestations
Acta Neurol Scand Kindstrand 106 253 2002 10.1034/j.1600-0404.2002.01336.x Peripheral neuropathy in acrodermatitis chronica atrophicans-effect of treatment
Ann Intern Med Reid 128 354 1998 10.7326/0003-4819-128-5-199803010-00003 The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study
Clin Infect Dis Patel 31 1107 2000 10.1086/318138 Death from inappropriate therapy for Lyme disease
Nat Med Levy 10 122 2004 10.1038/nm1145 Antibacterial resistance worldwide: causes, challenges and responses
Ann Intern Med Steere 138 761 2003 10.7326/0003-4819-138-9-200305060-00014 Duration of antibiotic therapy for Lyme disease
Am J Med Nowakowski 115 91 2003 10.1016/S0002-9343(03)00308-5 Long-term follow-up of patients with culture-confirmed Lyme disease
Clin Infect Dis Wang 31 1149 2000 10.1086/317465 Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease
Emerg Infect Dis Ramsey 8 398 2002 10.3201/eid0804.010222 Outcomes of treated human granulocytic ehrlichiosis cases
Arch Neurol Halperin 58 1345 2001 10.1001/archneur.58.9.1345 Of fleas and ticks on cats and mice
Ann Intern Med Buchwald 123 81 1995 10.7326/0003-4819-123-2-199507150-00001 Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest Health Care System
Prev Med Chen 15 74 1986 10.1016/0091-7435(86)90037-X The epidemiology of self-perceived fatigue among adults
Ann Intern Med Wessely 134 838 2001 10.7326/0003-4819-134-9_Part_2-200105011-00007 Chronic fatigue: symptoms and syndrome
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 54 484 2005 Monitoring progress in arthritis management-United States and 25 states, 2003
J Rheumatol Croft 20 710 1993 The prevalence of chronic widespread pain in the general population
Med Care Luo 43 1078 2005 10.1097/01.mlr.0000182493.57090.c1 Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index
MMWR Surveill Summ Zahran 54 1 2005 Health-related quality of life surveillance-United States, 1993-2002
Pediatrics Sigal 90 523 1992 10.1542/peds.90.4.523 Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia
Ann Intern Med Dinerman 117 281 1992 10.7326/0003-4819-117-4-281 Lyme disease associated with fibromyalgia
Ann Intern Med Lightfoot 119 503 1993 10.7326/0003-4819-119-6-199309150-00010 Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease: a cost-effectiveness analysis
Arthritis Rheum Wolfe 38 19 1995 10.1002/art.1780380104 The prevalence and characteristics of fibromyalgia in the general population
Int J Epidemiol Cairns 34 1340 2005 10.1093/ije/dyi129 Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms
JAMA Seltzer 283 609 2000 10.1001/jama.283.5.609 Long-term outcomes of persons with Lyme disease
Ann Intern Med Shadick 121 560 1994 10.7326/0003-4819-121-8-199410150-00002 The long-term clinical outcomes of Lyme disease: a population-based retrospective cohort study
Ann Intern Med Shadick 131 919 1999 10.7326/0003-4819-131-12-199912210-00003 Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease
Pediatrics Vazquez 112 e93 2003 10.1542/peds.112.2.e93 Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease
J Rheumatol Wang 25 2249 1998 Outcomes of children treated for Lyme disease
J Pediatr Salazar 122 591 1993 10.1016/S0022-3476(05)83541-3 Long-term outcome of Lyme disease in children given early treatment
Int J Epidemiol Shapiro 34 1437 2005 10.1093/ije/dyi241 Response to meta-analysis
Vector Borne Zoonotic Dis Shapiro 2 279 2002 10.1089/153036602321653879 Long-term outcomes of persons with Lyme disease
Arch Intern Med Imboden 108 115 1961 10.1001/archinte.1961.03620090065008 Convalescence from influenza
Arch Intern Med Imboden 103 406 1959 10.1001/archinte.1959.00270030062006 Brucellosis. III. Psychologic aspects of delayed convalescence
Arthritis Care Res Solomon 11 419 1998 10.1002/art.1790110514 Psychological factors in the prediction of Lyme disease course
Neurology Steiner 60 1888 2003 10.1212/01.WNL.0000077046.67754.60 Treating post-Lyme disease: trying to solve one equation with too many unknowns
J Infect Dis Radolf 192 948 2005 10.1086/432736 Post-treatment chronic Lyme disease: what it is not?
J Rheumatol Asch 21 454 1994 Lyme disease: an infectious and post-infectious syndrome
Ann Intern Med Sigal 136 413 2002 10.7326/0003-4819-136-5-200203050-00024 Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology
N Engl J Med Klempner 345 85 2001 10.1056/NEJM200107123450202 Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease
Vector Borne Zoonotic Dis Klempner 2 255 2002 10.1089/153036602321653842 Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease
Neurology Kaplan 60 1916 2003 10.1212/01.WNL.0000068030.26992.25 Cognitive function in post-treatment Lyme disease: do additional antibiotics help?
J Clin Psychiatry Ravdin 57 282 1996 Memory functioning in Lyme borreliosis
Arch Neurol Gaudino 54 1372 1997 10.1001/archneur.1997.00550230045015 Post-Lyme syndrome and chronic fatigue syndrome
Appl Neuropsychol Elkins 6 19 1999 10.1207/s15324826an0601_3 Psychological states and neuropsychological performances in chronic Lyme disease
Neurology Krupp 60 1923 2003 10.1212/01.WNL.0000071227.23769.9E Study and treatment of post Lyme disease (stop-LD): a randomized double-masked clinical trial
JAMA Steere 269 1812 1993 10.1001/jama.1993.03500140064037 The over diagnosis of Lyme disease
Clin Pediatr (Phila) Rose 33 663 1994 10.1177/000992289403301105 The over diagnosis of Lyme disease in children residing in an endemic area
Am J Med Sigal 88 577 1990 10.1016/0002-9343(90)90520-N The first one hundred patients seen at a Lyme disease referral center
Clin Infect Dis Burdge 16 558 1993 10.1093/clind/16.4.558 Experience of a referral center for patients with suspected Lyme disease in an area of non-endemicity: first 65 patients
Curr Med Chem Nieman 8 317 2001 10.2174/0929867013373570 A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury
J Antimicrob Chemother Labro 41 Suppl B 37 1998 10.1093/jac/41.suppl_2.37 Anti-inflammatory activity of macrolides: a new therapeutic potential?
Am J Med Nadelman 94 583 1993 10.1016/0002-9343(93)90208-7 Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study
J Am Acad Dermatol Berger 27 34 1992 10.1016/0190-9622(92)70152-6 Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease
Infection Phillips 26 364 1998 10.1007/BF02770837 A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated
J Vet Diagn Invest Greene 3 350 1991 10.1177/104063879100300416 Pseudospirochetes in animal blood being cultured for Borrelia burgdorferi
J Clin Microbiol Marques 38 4239 2000 10.1128/JCM.38.11.4239-4241.2000 Evaluation of a new culture medium for Borrelia burgdorferi
Infection Bayer 24 347 1996 10.1007/BF01716077 Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms: a PCR study of 97 cases
Clin Diag Lab Immunol Rauter 12 910 2005 10.1128/CDLI.12.8.910-917.2005 Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis
Infection Preac-Mursic 17 355 1989 10.1007/BF01645543 Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis
J Clin Neuroophthalmol Preac-Mursic 13 155 1993 First isolation of Borrelia burgdorferi from an iris biopsy
Antimicrob Agents Chemother Hunfeld 49 1294 2005 10.1128/AAC.49.4.1294-1301.2005 In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy
J Clin Microbiol Liveris 37 565 1999 10.1128/JCM.37.3.565-569.1999 Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens
J Clin Microbiol Misonne 36 3352 1998 10.1128/JCM.36.11.3352-3354.1998 Genetic heterogeneity of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in Belgium
Int J Antimicrob Agents Ruzic-Sabljic 25 474 2005 10.1016/j.ijantimicag.2005.02.007 Susceptibility of Borrelia afzelii strains to antimicrobial agents
Diagn Microbiol Infect Dis Yan 52 21 2005 10.1016/j.diagmicrobio.2004.12.002 The use of variable-number tandem-repeat mycobacterial interspersed repetitive unit typing to identify laboratory cross-contamination with Mycobacterium tuberculosis
Mt Sinai J Med Wormser 62 188 1995 Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections
Am J Trop Med Hyg Edwards 39 388 1988 10.4269/ajtmh.1988.39.388 Penicillin therapy in icteric leptospirosis
Lancet Watt 1 433 1988 10.1016/S0140-6736(88)91230-5 Placebo-controlled trial of intravenous penicillin for severe and late leptosirosis
J Spirochetal Tick-Borne Dis Fallon 5 94 1999 Repeated antibiotic treatment in chronic Lyme disease
MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention 51 18 2002 Sexually transmitted disease treatment guideline
Microbiology Alban 146 119 2000 10.1099/00221287-146-1-119 Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi
Antimicrob Agents Chemother Kazragis 40 2632 1996 10.1128/AAC.40.11.2632 In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites
Antimicrob Agents Chemother Pavia 46 132 2002 10.1128/AAC.46.1.132-134.2002 Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice
Antimicrob Agents Chemother Moody 38 1567 1994 10.1128/AAC.38.7.1567 Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice
J Infect Dis Malawista 170 1312 1994 10.1093/infdis/170.5.1312 Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment
J Infect Dis Bockenstedt 186 1430 2002 10.1086/345284 Detection of attenuated, non-infectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment
J Clin Microbiol Straubinger 35 111 1997 10.1128/JCM.35.1.111-116.1997 Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment
J Infect Dis Straubinger 181 1069 2000 10.1086/315340 Status of Borrelia burgdorferi infection after antibiotic treatment and effects of corticosteroids: an experimental study
Ann N Y Acad Sci Luft 539 352 1988 10.1111/j.1749-6632.1988.tb31869.x New chemotherapeutic approaches in the treatment of Lyme borreliosis
Infection Preac-Mursic 24 9 1996 10.1007/BF01780643 Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis
Arthritis Rheum Priem 44 1766 2001 Comparison of reculture and PCR for the detection of Borrelia burgdorferi in cell and tissue cultures after antibiotic treatment
Conn Med Varde 63 589 1999 Lyme disease: disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro
Program and abstracts of the 10th International Conference on Lyme Borreliosis and Other Tick-Borne Diseases (Vienna, Austria). Austrian Society for Hygeine, Microbiology, and Preventive Medicine Fallon 116 2005 Double-blind placebo-controlled retreatment with IV ceftriaxone for Lyme encephalopathy: clinical outcome [abstract 196]
Med Sci Monit Donta 9 136 2003 Macrolide therapy of chronic Lyme disease
Clin Infect Dis Donta 25 52 1997 10.1086/516171 Tetracycline therapy of chronic Lyme disease
Am J Pathol Barthold 143 419 1993 Chronic Lyme borreliosis in the laboratory mouse
J Leukoc Biol Craig-Mulius 77 710 2005 10.1189/jlb.0604356 Borrelia burgdorferi, an extracellular pathogen, circumvents osteopontin in inducing an inflammatory cytokine response
Am J Med Klempner 110 217 2001 10.1016/S0002-9343(00)00701-4 Intralaboratory reliability of serologic and urine testing for Lyme disease
Emerg Infect Dis Dumler 11 1828 2005 10.3201/eid1112.050898 Human granulocytic anaplasmosis and Anaplasma phagocytophilum
Int J Syst Evol Microbiol Dumler 51 2145 2001 10.1099/00207713-51-6-2145 Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and `HGE agent' as subjective synonyms of Ehrlichia phagocytophila
Clin Infect Dis Bakken 31 554 2000 10.1086/313948 Human granulocytic ehrlichiosis
Clin Microbiol Infect Blanco 8 763 2002 10.1046/j.1469-0691.2002.00557.x Human granulocytic ehrlichiosis in Europe
JAMA Bakken 272 212 1994 10.1001/jama.1994.03520030054028 Human granulocytic ehrlichiosis in the upper Midwest United States: a new species emerging?
Arch Intern Med Wallace 158 769 1998 10.1001/archinte.158.7.769 Human granulocytic ehrlichiosis in New York
MMWR Recomm Rep Chapman 55 RR-4 1 2006 Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States. A practical guide for physicians and other health-care professionals
Lancet Infect Dis Dumler 1 21 2001 10.1016/S1473-3099(09)70296-8 Tick-borne ehrlichioses: more of them, higher incidences, and greater clinical diversity
Med Clin North Am Olano 86 375 2002 10.1016/S0025-7125(03)00093-2 Human ehrlichioses
Clin Infect Dis Bakken 32 862 2001 10.1086/319350 Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis
Clin Infect Dis Bakken 34 22 2002 10.1086/323811 The serological response of patients infected with the agent of human granulocytic ehrlichiosis
Vector Borne Zoonotic Dis Aguero-Rosenfeld 2 233 2002 10.1089/153036602321653815 Diagnosis of human granulocytic ehrlichiosis: state of the art
Clin Infect Dis Belongia 32 1434 2001 10.1086/320160 Tickborne infections as a cause of nonspecific febrile illness in Wisconsin
Antimicrobial therapy and vaccine Bakken 2nd ed. 875 2002 Ehrlichia and Anaplasma species
Antimicrob Agents Chemother Horowitz 45 786 2001 10.1128/AAC.45.3.786-788.2001 Antimicrobial susceptibility of Ehrlichia phagocytophila
Antimicrob Agents Chemother Klein 41 76 1997 10.1128/AAC.41.1.76 Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins
Antimicrob Agents Chemother Maurin 47 413 2003 10.1128/AAC.47.1.413-415.2003 Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States
Scand J Infect Dis Casau 34 853 2002 10.1080/0036554021000026937 Treatment of human granulocytic ehrlichiosis during pregnancy and risk of perinatal transmission
N Engl J Med Edlow 339 1942 1998 Perinatal transmission of human granulocytic ehrlichiosis
N Engl J Med Horowitz 339 375 1998 10.1056/NEJM199808063390604 Perinatal transmission of the agent of human granulocytic ehrlichiosis
Pediatrics Krause 112 e252 2003 10.1542/peds.112.3.e252 Successful treatment of human granulocytic ehrlichiosis in children using rifampin
Pediatr Infect Dis J Moss 22 91 2003 10.1097/00006454-200301000-00023 Simultaneous infection with Borrelia burgdorferi and human granulocytic ehrlichiosis
J Pediatr Hematol Oncol Schiffman 23 324 2001 10.1097/00043426-200106000-00020 Ehrlichiosis infection in a 5-year-old boy with neutropenia, anemia, thrombocytopenia, and hepatosplenomegaly
Red book Ehrlichiosis 5th ed. 234 2000
Clin Infect Dis Buitrago 27 213 1998 10.1086/517678 Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin
N Engl J Med Elston 339 1941 1998 10.1056/NEJM199812243392615 Perinatal transmission of human granulocytic ehrlichiosis
Red book: 2006 report of the Committee of Infectious Diseases Pickering 27th ed. 281 2006 Ehrlichia and Anaplasma infections (human ehrlichioses)
Pediatr Infect Dis J Lochary 17 429 1998 10.1097/00006454-199805000-00019 Doxycycline and staining of permanent teeth
Vector Borne Zoonotic Dis Wormser 10.1089/vbz.2006.6.388 Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis
J Am Vet Med Assoc Madigan 190 445 1987 Equine ehrlichiosis in northern California: 49 cases (1968-1981)
Med Clin North Am Krause 86 361 2002 10.1016/S0025-7125(03)00092-0 Babesiosis
J Med Entomol Spielman 15 218 1979 10.1093/jmedent/15.3.218 Human babesiosis on Nantucket Island, USA: description of the vector, Ixodes (Ixodes) dammini, n. sp. (Acarina: Ixodidae)
Clin Microbiol Rev Homer 13 451 2000 10.1128/CMR.13.3.451 Babesiosis
JAMA Steketee 253 2675 1985 10.1001/jama.1985.03350420087023 Babesiosis in Wisconsin: a new focus of disease transmission
Am J Trop Med Hyg Krause 68 431 2003 10.4269/ajtmh.2003.68.431 Increasing health burden of human babesiosis in endemic sites
Ann Intern Med Herwaldt 124 643 1996 10.7326/0003-4819-124-7-199604010-00004 A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans
N Engl J Med Persing 332 298 1995 10.1056/NEJM199502023320504 Infection with a babesia-like organism in the western United States
Trans R Soc Trop Med Hyg Garnham 74 153 1980 10.1016/0035-9203(80)90232-1 Human babesiosis: European aspects
Ann Trop Med Parasitol Gorenflot 92 489 1998 10.1080/00034983.1998.11813307 Human babesiosis
J Clin Microbiol Wei 39 2178 2001 10.1128/JCM.39.6.2178-2183.2001 Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic
J Clin Microbiol Shih 35 450 1997 10.1128/JCM.35.2.450-454.1997 Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman
Revista Da Sociedade Brasileira de Medicina Tropical Rios 36 493 2003 10.1590/S0037-86822003000400010 Serological and parasitological study and report of the first case of human babesiosis in Colombia
Ann Intern Med Ruebush 86 6 1977 10.7326/0003-4819-86-1-6 Human babesiosis on Nantucket Island: clinical features
Clin Infect Dis Hatcher 32 1117 2001 10.1086/319742 Severe babesiosis in Long Island: review of 34 cases and their complications
Clin Infect Dis Falagas 22 809 1996 10.1093/clinids/22.5.809 Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin
Am J Med Rosner 76 696 1984 10.1016/0002-9343(84)90298-5 Babesiosis in splenectomized adults: review of 22 reported cases
N Engl J Med Ruebush 297 825 1977 10.1056/NEJM197710132971511 Human babesiosis on Nantucket Island: evidence for self-limited and subclinical infections
J Clin Microbiol Krause 29 1 1991 10.1128/JCM.29.1.1-4.1991 Geographical and temporal distribution of babesial infection in Connecticut
Pediatrics Krause 89 1045 1992 10.1542/peds.89.6.1045 Babesiosis: an underdiagnosed disease of children
N Engl J Med Krause 339 160 1998 10.1056/NEJM199807163390304 Persistent parasitemia following acute babesiosis
Transfusion McQuiston 40 274 2000 10.1046/j.1537-2995.2000.40030274.x Transmission of tickborne agents by blood transfusions: a review of known and potential risks in the United States
Am J Clin Pathol Healy 73 107 1980 10.1093/ajcp/73.1.107 Morphology of Babesia microti in human blood smears
J Infect Dis Krause 169 923 1994 10.1093/infdis/169.4.923 Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody
J Clin Microbiol Krause 34 2014 1996 10.1128/JCM.34.8.2014-2016.1996 Efficacy of an IgM serodiagnostic test for the rapid diagnosis of acute babesiosis
J Clin Microbiol Persing 30 2097 1992 10.1128/JCM.30.8.2097-2103.1992 Detection of Babesia microti by polymerase chain reaction
J Clin Microbiol Krause 34 2791 1996 10.1128/JCM.34.11.2791-2794.1996 Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia
Ann Intern Med Wittner 96 601 1982 10.7326/0003-4819-96-5-601 Successful chemotherapy of transfusion babesiosis
MMWR Morb Mortal Wkly Rep Centers for Disease Control 32 65 1983 Clindamycin and quinine treatment for Babesia microti infections
N Engl J Med Krause 343 1454 2000 10.1056/NEJM200011163432004 Atovaquone and azithromycin for the treatment of human babesiosis
JAMA Smith 256 2726 1986 10.1001/jama.1986.03380190096034 Transfusion-acquired babesiosis and failure of antibiotic treatment
Heart Lung Bonoan 27 424 1998 10.1016/S0147-9563(98)90089-9 Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone
Am J Trop Med Hyg Wittner 55 219 1996 10.4269/ajtmh.1996.55.219 Atovaquone in the treatment of Babesia microti infections in hamsters
N Engl J Med Weiss 344 773 2001 10.1056/NEJM200103083441014 The treatment of babesiosis
Ann Intern Med Raoult 107 944 1987 10.7326/0003-4819-107-6-944_2 Babesiosis, pentamidine, and cotrimoxazole
Trans R Soc Trop Med Hyg Shaio 91 214 1997 10.1016/S0035-9203(97)90229-7 Response of babesiosis to a combined regimen of quinine and azithromycin
Am J Trop Med Hyg Shih 59 509 1998 10.4269/ajtmh.1998.59.509 Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans
N Engl J Med Jacoby 303 1098 1980 10.1056/NEJM198011063031906 Treatment for transfusion-transmitted babesiosis by exchange transfusion
Transfus Med Rev Powell 16 239 2002 10.1053/tmrv.2002.33437 Exchange transfusion for malaria and Babesia infection
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.